文献速递血管炎

凋亡抑制蛋白拮抗剂SM164通过增强中性粒细胞脂肪酸氧化改善实验性MPO-ANCA相关性血管炎

Inhibitor of apoptosis proteins antagonist SM164 ameliorates experimental MPO-ANCA-associated vasculitis via enhancing fatty acid oxidation in neutrophils.
PubMed 文献 · Rheumatology (Oxford) · 2023-01-01

研究检测了19例MPO-AAV患者肾标本中凋亡抑制蛋白(IAPs)的表达,并用IAP泛抑制剂SM164治疗实验性自身免疫性血管炎(EAV)大鼠模型。结果显示cIAP1、cIAP2和XIAP在患者肾脏中表达上调,SM164显著减轻EAV大鼠肾损伤,机制涉及增强中性粒细胞脂肪酸氧化,从而抑制中性粒细胞活化及与内皮细胞黏附。

要点

  • MPO-AAV患者肾脏中cIAP1、cIAP2和XIAP表达较正常对照上调。
  • SM164显著减轻EAV大鼠肾损伤,转录组提示脂肪酸氧化与呼吸爆发改变。
  • SM164抑制MPO-ANCA阳性IgG或患者血清诱导的中性粒细胞活化,该作用可被脂肪酸氧化抑制逆转。

核心结论

  • 抑制IAPs的SM164通过增强中性粒细胞内脂肪酸氧化在AAV中发挥保护作用。

研究设计与样本

  • 研究收集19例MPO-AAV患者肾脏标本检测IAPs表达,并用IAP泛抑制剂SM164治疗EAV大鼠模型,结合肾皮质RNA测序、富集分析及中性粒细胞和内皮细胞功能实验。

主要发现

  • cIAP1、cIAP2和XIAP在AAV患者肾脏中的表达较正常对照上调。
  • SM164显著减轻EAV大鼠的肾损伤。
  • 转录组分析显示SM164处理后脂肪酸氧化和呼吸爆发发生显著改变。
  • SM164抑制MPO-ANCA阳性IgG或MPO-AAV患者血清诱导的中性粒细胞活化,该抑制作用可被脂肪酸氧化的基因沉默或药理抑制所消除。
  • SM164抑制中性粒细胞与内皮细胞的黏附,对MPO-AAV患者血清诱导的内皮损伤影响很小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of life-threatening autoimmune diseases. Inhibitors of apoptosis proteins (IAPs) are a class of molecules engaged in cell death and inflammation, interventions of which are proven effective in a number of inflammatory diseases. Here we tested whether targeting IAPs could ameliorate AAV and explored the potential mechanism. METHODS: We collected 19 kidney specimens from patients with myeloperoxidase (MPO)-AAV to investigate the expression of IAPs. The IAP pan-inhibitor SM164 was used to treat the experimental autoimmune vasculitis (EAV) rat model of AAV. RNA sequencing of renal cortex and enrichment analysis were developed to interpret gene expression. Functional experiments were performed to investigate the role of SM164 on neutrophils and endothelial cells. RESULTS: The expression of three IAPs (cIAP1, cIAP2 and XIAP) was upregulated in kidneys of AAV patients compared with normal controls. SM164 dramatically reduced renal injury in EAV rats. Transcriptomic analysis revealed prominent alterations in fatty acid oxidation and respiratory burst following SM164 treatment. Functional studies demonstrated that SM164 inhibited neutrophil activation induced by MPO-ANCA positive IgG or serum from MPO-AAV patients, and such inhibitory effect was abolished by gene silencing or pharmacological inhibition of fatty acid oxidation. SM164 also inhibited the adhesion of neutrophils to endothelial cells with little effect on the endothelial injury induced by serum from MPO-AAV patients. CONCLUSION: Inhibition of IAPs with SM164 played a protective role in AAV through enhancing intracellular fatty acid oxidation in neutrophils.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Wang LY, Wang RX, Wang C, et al. Inhibitor of apoptosis proteins antagonist SM164 ameliorates experimental MPO-ANCA-associated vasculitis via enhancing fatty acid oxidation in neutrophils. Rheumatology (Oxford). 2023. PMID: 36308438. doi:10.1093/rheumatology/keac621

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。